The 340B program allows qualifying safety net providers that serve a high proportion of low-income, uninsured, and underinsured patients to purchase outpatient drugs at a discounted price from pharmaceutical manufacturers. GNYHA continues to educate lawmakers on the importance of the 340B program, and will keep members informed on program updates.
8 Items in 340B Program
MACs to Reprocess Medicare 2022 340B Drug Claims Upon Request; Action Required
October 19, 2022
SCOTUS to Hear AHA Challenge to 340B Rate Cut, Declines to Hear Challenge to Site-Neutral Cut
July 2, 2021
CMS Proposes Additional 340B Drug Cuts, Makes Certain Telehealth Provisions Permanent, and Responds to Allina Ruling
August 6, 2020